University of Baghdad Researchers Publish New Data on Ophthalmic Antiinfectives (Modification and Characterization of Some New Levofloxacin Heterocyclic Derivatives as COX-2 Enzyme Inhibitors and Evaluate Their Efficacy Pharmacokinetics by...).

MLA

“University of Baghdad Researchers Publish New Data on Ophthalmic Antiinfectives (Modification and Characterization of Some New Levofloxacin Heterocyclic Derivatives as COX-2 Enzyme Inhibitors and Evaluate Their Efficacy Pharmacokinetics By...).” Drug Week, Nov. 2024, p. 2866. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=180891481&authtype=sso&custid=ns315887.

APA

University of Baghdad Researchers Publish New Data on Ophthalmic Antiinfectives (Modification and Characterization of Some New Levofloxacin Heterocyclic Derivatives as COX-2 Enzyme Inhibitors and Evaluate Their Efficacy Pharmacokinetics by...). (2024). Drug Week, 2866.

Chicago

“University of Baghdad Researchers Publish New Data on Ophthalmic Antiinfectives (Modification and Characterization of Some New Levofloxacin Heterocyclic Derivatives as COX-2 Enzyme Inhibitors and Evaluate Their Efficacy Pharmacokinetics By...).” 2024. Drug Week, November, 2866. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=180891481&authtype=sso&custid=ns315887.